On The Path To Regeneration: NovaGo’s New Approach To Stroke

 
• By Jo Shorthouse

Zurich University spin-off NovaGo Therapeutics is taking a regenerative approach to stroke, and with €10m funding from a series A round to proceed its preclinical asset into Phase I, it is hoping to be in the clinic within two years.

Tree
NovaGo is hoping to prove CNS regeneration is possible and efficacious • Source: Shutterstock

More from Cell Therapies

More from Advanced Therapies